PATENT CLAIM ANALYSIS

Application Number: 15752854
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "083000"]

Abstract:
Provided herein are optically active compounds of the formulae (ii); and (III) and pharmaceutical compositions thereof. Also provided herein are processes of making these compounds and resolving the racemic mixture or the enrichment of same with in one of its enantiomers to provide (R)- and (S)-1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-N,N′-bis(ethylene)phosphoramidate, and methods of treating cancer comprising administering such compounds.

Claim (Index 2):
The compound (S)-1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-N,N\u2032-bis(ethylene)phosphoramidate: or a isotopic variant thereof, or a pharmaceutically acceptable solvate or hydrate thereof.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 88.0
- Lexical Diversity: 1.51786
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15557053', '15877103', '14423359', '15339041', '15553088']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7252759233484685
- 35 USC 102 Novelty (BERT): 0.5060458077411005
- Combined Prediction Score: 0.7033529117877316
- Mean Citation Score: 185.671668
- Max Citation Score: 196.10022
- Similarity Product: 124.95958321585536

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test